Brineura
Chemical Name | cerliponase alfa |
Dosage Form | Injection (intraventricular; 150 mg/5 ml) |
Drug Class | Enzymes |
System | Nervous |
Company | BioMarin Pharmaceutical Inc. |
Approval Year | 2017 |
Indication
- To slow the loss of ambulation associated with late infantile neuronal ceroid lipofuscinosis type 2 in patients ≥ 3 years of age.